Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Melanoma × Endoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Barrett Esophagus 13 Esophageal Neoplasms 7 Rectal Neoplasms 6 Colorectal Neoplasms 6 Adenocarcinoma Of Esophagus 6 Nasopharyngeal Carcinoma 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Polyps 3 Lung Neoplasms 3 Precancerous Conditions 2 Pathologic Complete Response 2 Hyperplasia 2 Gastroesophageal Reflux 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Adenomatous Polyposis Coli 2 Adenocarcinoma 2 Urogenital Neoplasms 1 Upper Tract Urothelial Carcinoma 1 Thyroid Neoplasms 1 Stomach Ulcer 1 Stomach Diseases 1 Recurrence 1 Polyposis, Gastric 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Metaplasia 1

Interventions

pembrolizumab 285 Nivolumab 258 Ipilimumab 236 aldesleukin 134 Cyclophosphamide 134 Interleukin-2 104 Temozolomide 75 Dacarbazine 74 trametinib 70 Vemurafenib 69 fludarabine 67 dabrafenib 65 fludarabine phosphate 61 sargramostim 44 binimetinib 44 Radiosurgery 44 Biopsy 43 Paclitaxel 42 Bevacizumab 42 incomplete Freund's adjuvant 39 encorafenib 37 Radiotherapy 36 Cisplatin 36 CTLA-4 Antigen 36 atezolizumab 35 Carboplatin 35 cobimetinib 32 Magnetic Resonance Spectroscopy 31 Introns 30 spartalizumab 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04879654 2024-03-05

SNMM

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡